
4개의 파트로 구성됨.

Part 1
Part 2
Part 3
Part 4

과제요약
연구단계(총연구기간)		연구단계(당해년도)	
연구목표	
 
  Byte     ※총 4,000Byte(한글 2,000글자, 영문 4,000자)까지 가능합니다.
연구내용	
 
  Byte     ※총 4,000Byte(한글 2,000글자, 영문 4,000자)까지 가능합니다.
기대효과	
 
  Byte     ※총 4,000Byte(한글 2,000글자, 영문 4,000자)까지 가능합니다.
연구개발성과	
 
  Byte     ※총 4,000Byte(한글 2,000글자, 영문 4,000자)까지 가능합니다.
국문색인	
  
  
  
  
 영문색인	
  
  
  
  

<https://www.fic.nih.gov/programs/pages/korea-visiting-scientists.aspx>

https://scholar.google.co.kr/citations?user=TUK927cAAAAJ&hl=ko
http://orcid.org/0000-0002-4674-7682

PARP-1 억제제, JPI-289의 약동/약력학적 특성 및 안전성, 내약성에 관한 무작위, 위약대조, 이중맹검, 평행군, 단회/반복투여, 단계적 증량 임상연구

임상약리학과 한성필 레지던트가 6월 24일 체코 프라하에서 열린 유럽임상약리학회에서 'PARP-1 억제제, JPI-289의 약동/약력학적 특성 및 안전성, 내약성에 관한 무작위, 위약대조, 이중맹검, 평행군, 단회/반복투여, 단계적 증량 임상연구'라는 논문을 발표해 젊은임상약리학자 포스터상을 수상했다.

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Dose JPI-289, A Novel Poly (ADP-Ribose) Polymerase-1 Inhibitor in First-In-Human Study of Healthy Volunteers

## htdream, KRI, NTIS

+ 과학기술인등록번호 : 10203824
+ [HTDREAM 보건의료 R&D 포탈](https://www.htdream.kr/) | sungpilhan | against74!!! | |
+ [KRI 한국연구자정보 / 10203824](https://www.kri.go.kr/) | pnumdphd | against74! | EDISON, 서울성모병원 학력정보 |
+ [NTIS](http://www.ntis.go.kr/ThMain.do) // sungpilhan/against74!
+ [NRF] // pnumdphd / against74!
+ [인사혁신처](https://www.hrdb.go.kr/) // shanmdphd15/against74!

## KRI 기준 

- https://www.kri.go.kr/kri2
- KRI에서는 SCOPUS 논문의 경우 elsevier 사에서 운영하는 www.scopus.com 사이트에 등록이 되어있는 논문만 검증이 됩니다. 
- 또한 SCI 논문의 경우 THOMSON REUTERS의 Web of Science 사이트에 등록된 논문만 검증이 됩니다.

# 내 정보

## Thesis

- 부산대학교 의학박사 의학과 분자세포생물학및유전학 Molecular Cell Biology and Genetics 2015년 2월 27일 
- Comprehensive Flow Cytometric Immunophenotyping of Peripheral Blood and Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases , 2015년 2월 부산대학교 의학전문대학원 의과학과 한성필
- RISS / shanmdphd / against74! http://www.riss.kr/search/detail/DetailView.do?p_mat_type=be54d9b8bc7cdb09&control_no=ad9cc59ace13f4e4ffe0bdc3ef48d419#redirect
- PDF http://dcollection.pusan.ac.kr/jsp/common/DcLoOrgPer.jsp?sItemId=000000098299

- abstract: 
We performed unbiased, comprehensive immunophenotyping of cerebrospinal fluid (CSF) and blood leukocytes in 221 subjects referred for the diagnostic work-up of neuroimmunological disorders to obtain insight about disease-specific phenotypes of intrathecal immune responses. Quantification of 14 different immune cell subsets, coupled with the assessment of their activation status, revealed physiological differences between intrathecal and systemic immunity, irrespective of final diagnosis. Our data are consistent with a model where the CNS shapes intrathecal immune responses to provide effective protection against persistent viral infections, especially by memory T cells, plasmacytoid dendritic cells, and CD56bright NK cells. Our data also argue that CSF immune cells do not simply reflect cells recruited from the periphery. Instead, they represent a mixture of cells that are recruited from the blood, have been activated intrathecally and leave the CNS after performing effector functions. Diagnosis-specific differences provide mechanistic insight into the disease process in the defined subtypes of multiple sclerosis (MS), neonatal onset multisystem inflammatory disease, and Aicardi–Goutières syndrome. This analysis also determined that secondary-progressive MS patients are immunologically closer to relapsing–remitting patients as compared with patients with primary-progressive MS. Because CSF immunophenotyping captures the biology of the intrathecal inflammatory processes, it has the potential to guide optimal selection of immunomodulatory therapies in individual patients and monitor their efficacy. Our study adds to the increasing number of publications that demonstrate poor correlation between systemic and intrathecal inflammatory biomarkers in patients with neuroimmunological diseases and stresses the importance of studying immune responses directly in the intrathecal compartment.

## Impact Factor

+ 임팩트 팩터 Impact Factor 검색하는 사이트 <https://jcr.incites.thomsonreuters.com/JCRJournalHomeAction.action?year=&edition=&journal=>
+ http://medlib.yu.ac.kr/SCI.htm

## International

+ ORCID Sue : 0000-0003-3898-0721
+ ORCID Phil | 0000-0002-4674-7682 | against74! Google Login <http://orcid.org/0000-0002-4674-7682>
+ [Publon](https://publons.com/author/1265484/sungpil-han#profile) | pil.han@gmail.com | against |
+ [Scopus](https://scopus.com) | shan@acp.kr | against74!!
+ [Scopus Author ID: 46960915800](https://www.scopus.com/authid/detail.uri?authorId=46960915800)1
+ [Web of Science](http://apps.webofknowledge.com) | pil.han@gmail.com | against74! | |

### Other Government

* EDISON // shan / against74!
* [식약처](https://rnd.mfds.go.kr) // sungpilhan/against74!
* https://ezdrug.mfds.go.kr/
* [질병관리본부 CDC](http://ede.cdc.go.kr) // wreckord/against74!
* http://hn.nanet.go.kr 국회도서관 shanmdphd/against74!
* KONECT.or.kr sungpilhan/against74!

* [이공분야 기초연구사업 > 학문후속세대양성 > 박사후국내·외연수]  http://www.nrf.re.kr/biz/info/info/view?biz_no=352


SCI/비SCI    
논문명 
 
NTIS
논문초록    
학술지구분   
학술지명    
 
SCI저널검색
피인용지수(Impact Factor)    
 * 해당 논문이 SCI급인 경우 SCI저널검색을 통해 학술지를 입력하면 피인용지수가 자동으로 등록됩니다.
학술지 시작페이지   
학술지 종료페이지   
ISSN-NO 
발행기관    
학술지발행일자 
...
저자구분    
저자  
논문번호    
학술지권호   
학술지PubMedId 
대표논문여부  예  아니오



### 내 논문 임팩트 팩터

- 5th https://jcr.incites.thomsonreuters.com/JCRJournalProfileAction.action?pg=JRNLPROF&journalImpactFactor=1.61&year=2016&journalTitle=MATHEMATICAL%20MEDICINE%20AND%20BIOLOGY-A%20JOURNAL%20OF%20THE%20IMA&edition=SCIE&journal=MATH%20MED%20BIOL

## 내 논문


A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy
SC Wuest, JH Edwan, JF Martin, S Han, JSA Perry, CM Cartagena, ...
Nature medicine 17 (5), 604-609 175 2011

Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis
JSA Perry, S Han, Q Xu, ML Herman, LB Kennedy, G Csako, B Bielekova
Science translational medicine 4 (145), 145ra106-145ra106   88  2012

SNAI1 is involved in the proliferation and migration of glioblastoma cells
SP Han, JH Kim, ME Han, HE Sim, KS Kim, S Yoon, SY Baek, BS Kim, ...
Cellular and molecular neurobiology 31 (3), 489-496 54  2011
PMID: 21225336 DOI: 10.1007/s10571-010-9643-4
http://apps.webofknowledge.com/Search.do?product=WOS&SID=V24WO1s4yLmxjGGIFZq&search_mode=GeneralSearch&prID=d2d6f109-e51d-4874-8e09-85f441c0749c

Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases
S Han, YC Lin, T Wu, AD Salgado, I Mexhitaj, SC Wuest, E Romm, ...
The Journal of Immunology 
192 (6), 2551-2563  29  2014

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Oral Doses of CJ-12420 (Tegoprazan), A Novel Potassium-Competitive Acid Blocker (P-CAB) in Healthy Male Subjects
S Han, HY Choi, YH Kim, JY Nam, GS Song, HS Lim, KS Bae
Clinical Therapeutics ISSN: 01492918 
39 (8), e97-e98     2017

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Dose JPI-289, A Novel Poly (ADP-Ribose) Polymerase-1 Inhibitor in First-In-Human Study of Healthy Volunteers
S Han, YH Kim, HY Choi, DJ Soh, JM Kim, JW Nam, JW Kim, KS Bae, ...
Clinical Therapeutics ISSN: 01492918 
39 (8), e48     2017

Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of CTB-001, Recently Developed Bivalirudin
S Han, HY Choi, YH Kim, WJ Kim, KS Bae, HS Lim
Clinical Therapeutics ISSN: 01492918 
39 (8), e54     2017

The effects of interleukin-2 on immune response regulation
RS Waters, JSA Perry, SP Han, B Bielekova, T Gedeon
Mathematical Medicine and Biology: A Journal of the IMA ISSN: 1477-8599
, dqw021        2017
PMID: 28339682 DOI: 10.1093/imammb/dqw021

Effects of single oral administration of SKI2670, gonadotropin-releasing hormone (GnRH) antagonist, in healthy pre-menopausal women
S Han, K Lim, S Cho, J Kim, S Choe, J Jung, J Ghim, H Jeong, T Yoo, ...
Fertility and Sterility ISSN: 00150282
106 (3), e273       2016

Inhibitory effects of CD25 blockade on development of pro-inflammatory innate lymphoid cells is associated with decreased intrathecal inflammation in MS
SP Han, JSA Perry, Q Xu, LB Kennedy, B Bielekova
JOURNAL OF NEUROIMMUNOLOGY 253 (1-2), 67-67     2012
http://www.jni-journal.com/article/S0165-5728(12)00304-9/pdf

Comprehensive monitoring of intrathecal immune cells in patients with multiple sclerosis by 12-color flow cytometric immunophenotyping
SP Han, AD Salgado, E Romm, B Bielekova
JOURNAL OF NEUROIMMUNOLOGY 253 (1-2), 98-98     2012
http://www.jni-journal.com/article/S0165-5728(12)00304-9/pdf
http://dx.doi.org/10.1016/j.jneuroim.2012.10.001



Flow Cytometric Immunophenotyping of the Blood and CSF of Patients with Multiple Sclerosis (P02. 081)
S Han, A Salgado, T Alfahad, B Bielekova
Neurology 78 (1 Supplement), P02. 081-P02. 081      2012
http://www.neurology.org/content/78/1_Supplement/P02.081.short?sid=34bf7122-827d-4986-a429-9bb2a9aba166

Daclizumab Inhibits Expansion of Antigen (Ag)-Specific T Cells by Blocking IL-2 Transpresentation by Dendritic Cells
S Wuest, S Han, J Martin, D Maric, B Bielekova
NEUROLOGY 76 (9), A240-A240     2011

Effects of Long-Term (> 5 Years) Daclizumab Therapy on Lymphocyte Subpopulations-Comparison of Immediate Ex-Vivo Immunophenotyping with Commercially-Available Assay
S Han, I Cortese, B Bielekova
NEUROLOGY 76 (9), A239-A240     2011

Opposing regulation between lymphoid tissue inducer cells and immunoregulatory CD56bright NK cells underlies therapeutic benefit of daclizumab in MS
http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=22&SID=V24WO1s4yLmxjGGIFZq&page=1&doc=1
http://www.jni-journal.com/article/S0165-5728(10)00345-0/pdf


